uMotif – one of the clinical research technology market’s fastest-growing companies – has acquired site platform provider ClinOne. The acquisition expands uMotif’s existing strengths in improving both the site and patient journey. uMotif’s eCOA/ePRO platform is the most modern solution on the market today, regularly achieving unprecedented levels of patient compliance in clinical trials and real-world studies by guiding the patient through the trial. By giving sponsors and CROs a user-friendly eCOA/ePRO solution that puts the needs of patients first, uMotif ensures that customers capture the large amounts of data necessary to maximize the success of the trial.
Read the full article: uMotif Buys ClinOne //
Source: https://www.prweb.com/releases/umotif-buys-clinone-integrates-robust-platform-of-site-applications-including-econsent-into-the-most-modern-ecoaepro-platform-for-clinical-trials-real-world-studies-302237509.html